Location History:
- Westmont, IL (US) (1984)
- New London, WI (US) (1991)
- Arlington, VA (US) (2000)
- Mundeline, IL (US) (1999 - 2008)
- Mundelein, IL (US) (1989 - 2016)
Company Filing History:
11 out of 2,483 
6 out of 151 
3 out of 1,152 
Years Active: 1984-2016
Title: Richard J. Johnson: Innovator in Medical Treatment and Transplantation
Introduction
Richard J. Johnson is a noted inventor based in Mundelin, Illinois, with a remarkable portfolio of 21 patents. His work primarily focuses on medical innovations that provide solutions for critical health issues such as rheumatoid arthritis and allograft rejection.
Latest Patents
Among his most recent inventions, Johnson has developed methods that utilize Factor H for the treatment of rheumatoid arthritis. This invention outlines a composition comprising Factor H, aimed at preventing or inhibiting allograft rejection in recipients. Additionally, Johnson's patents also emphasize the potential effectiveness of administering immunosuppressants in conjunction with Factor H to enhance treatment outcomes.
Career Highlights
Johnson has made significant contributions to the field of biomedical research through his roles at prominent companies. He has worked with Baxter International Inc. and Baxalta GmbH, where he contributed to the development of innovative medical therapies.
Collaborations
Throughout his career, Johnson has collaborated with industry professionals, including notable colleagues Neng S. Ung-Chhun and Shawn F. Bairstow. These partnerships underscore the collective effort in advancing medical technology and improving patient care through innovative therapies.
Conclusion
Richard J. Johnson's contributions to medical science through his patents demonstrate the vital role of innovation in addressing healthcare challenges. His focus on Factor H as a treatment modality illustrates the potential for groundbreaking advancements in the field of immunology and transplantation, ultimately impacting the lives of countless patients.